| 股票代码 | 603351 | 当期评分 | ||||
| 股票名称 | 威尔药业 | |||||
| 报告日期 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | -- | -- | -- | 1.3896 | 0.4862 | ✘ |
| 销售净利润率(%) | 13.1992 | 15.4781 | 13.9515 | 14.5452 | 14.7771 | ✔ |
| 销售毛利率(%) | 39.3487 | 34.0899 | 30.3774 | 33.6853 | 36.8443 | ✔ |
| 净资产收益率(%) | 16.61 | 20.16 | 18.19 | 10.32 | 5.93 | ✘ |
| 营业增长率(%) | 11.982 | 24.2937 | 15.4645 | 9.8951 | -22.5666 | ✘ |
| 净利润增长率(%) | 21.3767 | 45.754 | 4.0759 | 14.5719 | -31.5041 | ✘ |
| 每股收益(%) | 1.47 | 2.15 | 2.24 | 1.39 | 0.58 | ✔ |
| 现金流量比率(%) | 87.8336 | 40.4042 | 35.2946 | 65.178 | 24.3369 | ✔ |
| 三项费用比重(%) | 21.6192 | 16.7266 | 12.3359 | 12.9953 | 17.3841 | ✔ |
| 每股净资产(¥) | 9.6953 | 10.66 | 12.2922 | 13.2987 | 9.7589 | ✔ |
| 流动比率(%) | 1.7586 | 1.8106 | 1.7617 | 4.1375 | 2.2842 | ✔ |
| 速动比率(%) | 1.3178 | 1.2755 | 1.2033 | 3.5601 | 1.8777 | ✔ |
| 现金比率(%) | 50.2562 | 42.9346 | 22.385 | 90.9278 | 90.9278 | ✔ |
| 总资产利润率(%) | 13.5529 | 16.2074 | 14.5808 | 11.3046 | 5.0199 | ✔ |
| 主营利润比重% | 242.764 | 188.2756 | 185.7769 | 192.5041 | 214.197 | ✔ |
| 应收账款(万元) | 8,775.26 | 7,947.14 | 8,518.70 | 9,424.24 | 7,513.54 | ✔ |
| 应收票据(万元) | 1,702.32 | 5,261.65 | 6,753.92 | 7,206.04 | 2,737.94 | ✘ |
| 预付款项(万元) | 859.03 | 973.78 | 1,427.20 | 1,653.20 | 1,811.52 | ✔ |
| 存货(万元) | 6,433.42 | 9,439.49 | 10,088.11 | 11,488.78 | 10,609.96 | ✔ |
| 在建工程(万元) | -- | 10,111.80 | 15,596.55 | 22,133.59 | 51,660.62 | ✘ |
| 应付款项(万元) | 6,051.95 | 7,122.94 | 5,584.62 | 6,885.33 | 12,549.39 | ✔ |
| 长期借款(万元) | 12.07 | -- | -- | -- | -- | ✔ |
| 未分配利润(万元) | 27,206.22 | 8,664.56 | 15,689.53 | 23,194.88 | 26,555.18 | ✔ |
| 商誉(万元) | -- | -- | -- | -- | -- | ✔ |
| 流动资产(万元) | 34,358.32 | 40,613.00 | 48,994.66 | 63,497.15 | 95,757.01 | ✔ |
| 流动负债(万元) | 14,593.67 | 17,639.63 | 18,064.54 | 19,898.43 | 26,104.69 | ✔ |
威尔药业603351评分结果 | 60.61分 | 卖出/减持 | ||||